Historical record - last NADAC effective date: 9/19/2018
Product Information
METOPROLOL TARTRATE 50 MG TAB is a generic product labeled by Cambridge Therapeutics Technologies, LLC, priced at $0.0203 per EA under NDC 70882013360. Its NADAC has been published 47 times since Nov 15, 2017.
FDA first approved this application on Sep 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Cambridge Therapeutics Technologies, LLCNDC
70882013360
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/19/2018
Active Ingredients
METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077739FDA Approved
9/11/2007
TE Code
AB
On Market Since
9/11/2007
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL TARTRATE 50 MG TAB has been published 47 times since Nov 15, 2017, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0203 per EA |
|---|---|
| All-time high | $0.0215 (Apr 11, 2018) |
| All-time low | $0.0193 (Jun 20, 2018) |
| Median price | $0.0206 |
| Average price | $0.0206 |
| Largest weekly change | -8.9% (Jun 20, 2018) |
| Weeks tracked | 47 |
| Tracking since | Nov 15, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-4.5%
Last surveyed Oct 3, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cambridge Therapeutics Technologies, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL TARTRATE 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL TARTRATE 50 MG TAB, manufactured by Cambridge Therapeutics Technologies, LLC, is $0.0203 per EA (NDC 70882013360), effective Oct 3, 2018.
How has the price of METOPROLOL TARTRATE 50 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL TARTRATE 50 MG TAB has declined 4.5%. It has been tracked across 47 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for METOPROLOL TARTRATE 50 MG TAB?
Since Nov 15, 2017, the NADAC for METOPROLOL TARTRATE 50 MG TAB has ranged from a low of $0.0193 (Jun 20, 2018) to a high of $0.0215 (Apr 11, 2018), with a median of $0.0206 per EA.
Are there cheaper alternatives to METOPROLOL TARTRATE 50 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL TARTRATE 50 MG TAB, is $0.0195 per EA — about 4% below METOPROLOL TARTRATE 50 MG TAB.
Who manufactures METOPROLOL TARTRATE 50 MG TAB?
METOPROLOL TARTRATE 50 MG TAB (NDC 70882013360) is labeled by Cambridge Therapeutics Technologies, LLC, and CMS classifies it as a generic product.